Glenmark

Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India

Over 10 leading government and private hospitals in India are being enrolled for the study, Glenmark estimates study completion by…

Additionally over 3,00,000 beneficiaries to be reached across Himachal Pradesh, Madhya Pradesh and Gujarat via tele-medicine by…

Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle…

Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg is the the generic version of Exjade 1 Tablets for Oral…

The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the…

The company's consolidated net profit was at Rs 2,555.42 million in Q2 FY 2019-20 and consolidated EBITDA was at 2.3 per cent to…

According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is…

Glenmark’s current portfolio consists of 163 products authorised for distribution in the US marketplace and 45 ANDA’s pending…

The United States Food and Drug Administration (US FDA) also warned the firm that until it corrects all violations, it may…